• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804225-12
Device Problems Improper or Incorrect Procedure or Method (2017); Defective Device (2588); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Myocardial Infarction (1969); Thrombosis/Thrombus (4440)
Event Date 01/08/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.The additional xience skypoint device referenced in b5 is filed under separate medwatch report number.
 
Event Description
It was reported that the first procedure was performed on (b)(6) 2023 to treat a lesion with four xience skypoint stent delivery systems (sds).A 2.5x23 mm and 2.25x12 mm xience skypoint stent were implanted in the mid left anterior descending coronary artery (mlad), one on the circumflex (cx), and the last one on the right coronary artery (rca).The patient was discharged on 1/06/23 with plavex.On the (b)(6) 2023 the patient experienced chest pain and was diagnosed with st elevated myocardial infarction (stemi).The lad was found to be under total thrombotic occlusion with in stent restenosis in the ostial,proximal, mid and distal lad with 100% stenosis.After pre dilating the lesion with a 3.25 non-compliant balloon (nc) to the proximal and distal stent in the mid lad and a 3.00mm non-compliant balloon (nc) in the distal lad.A 2.75x28 xience skypoint sds was implanted in mid lad, distal to the previously implanted stent.Reportedly, the stents were undersized to the vessel.No additional information was provided.
 
Event Description
Subsequent to the initially filed report, it was reported that it was the stents in the lad which were undersized [size chosen was small for the vessel].No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.The reported patient effect(s) of thrombosis, angina and myocardial infarction are listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as a known patient effect(s) of coronary stenting procedures.Reportedly, the stents were undersized to the vessel.Subsequent to the initially filed report, it was reported that it was the stents in the lad which were undersized [size chosen was small for the vessel].It should be noted that the xience skypoint everolimus eluting coronary stent system instruction for use states: under-expansion of the stent may result in stent movement.Care must be taken to properly size the stent to ensure that the stent is in full contact with the arterial wall upon deflation of the balloon.All efforts should be made to ensure that the stent is not under-dilated.In this case, it cannot be determined if the instructions for use related to failure to follow steps/instructions caused and/or contributed to the reported patient effects.There is no indication of a product quality issue with respect to manufacture, design or labeling.H6: medical device problem code: 2588 removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16765578
MDR Text Key313541225
Report Number2024168-2023-03980
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648232985
UDI-Public08717648232985
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/03/2024
Device Model Number1804225-12
Device Catalogue Number1804225-12
Device Lot Number2030141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/24/2023
Initial Date FDA Received04/18/2023
Supplement Dates Manufacturer Received05/04/2023
Supplement Dates FDA Received05/26/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age57 YR
Patient SexMale
-
-